Cargando…
Transcription associated cyclin-dependent kinases as therapeutic targets for prostate cancer
Transcriptional deregulation has emerged as a hallmark of several cancer types. In metastatic castration-resistant prostate cancer, a stage in which systemic androgen deprivation therapies fail to show clinical benefit, transcriptional addiction to the androgen receptor is maintained in most patient...
Autores principales: | Constantin, Theodora A., Greenland, Kyle K., Varela-Carver, Anabel, Bevan, Charlotte L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9187515/ https://www.ncbi.nlm.nih.gov/pubmed/35568739 http://dx.doi.org/10.1038/s41388-022-02347-1 |
Ejemplares similares
-
Therapeutic targeting of transcriptional cyclin-dependent kinases
por: Galbraith, Matthew D., et al.
Publicado: (2018) -
The CDK7 inhibitor CT7001 (Samuraciclib) targets proliferation pathways to inhibit advanced prostate cancer
por: Constantin, Theodora A., et al.
Publicado: (2023) -
Cyclin-dependent kinase 7 is a therapeutic target in high-grade glioma
por: Greenall, S A, et al.
Publicado: (2017) -
Cyclin-dependent kinases
por: Malumbres, Marcos
Publicado: (2014) -
Concomitant Presence of p16/Cyclin‐dependent Kinase 4 and Cyclin D/Cyclin‐dependent Kinase 4 omplexes in LNCaP Prostatic Cancer Cell Line
por: Itoh, Noriyuki, et al.
Publicado: (1997)